TITLE

Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry

AUTHOR(S)
Carpelan-Holmsfröm, M.; Nordling, S.; Pukkala, E.; Sankila, R.; Lüttges, J.; Klöppel, G.; Haglund, C.
PUB. DATE
March 2005
SOURCE
Gut;Mar2005, Vol. 54 Issue 3, p385
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Worldwide survival data for ductal adenocarcinoma of the pancreas are the lowest among the 60 most frequent types of organ cancers. Hence published data on long time survivors of this disease are controversial. We performed a nationwide study comprising all Finnish patients diagnosed with pancreatic cancer in the period 1990-1996 who survived for at least five years alter diagnosis. Methods: Data on patients registered as five year survivors of pancreatic cancer were obtained from the Finnish Cancer Registry and Statistics Finland. Slides or paraffin blocks were collected from patients recorded as having histologically proven pancreatic ductal adenocarcinoma (PDAC) and were re- evaluated in a double blind fashion by three pathologists with special expertise in pancreatic pathology. Results: Between 1990 and 1996, the Finnish Cancer Registry recorded 4922 pancreatic cancer patients, 89 of whom survived for at least five years. Reviewing this series of patients revealed 45(49%) non-PDACs and 18 cases without histological verification. In 26 patients recorded as having histologically proven PDAC, re-evaluation of histological specimens confirmed PDAC in only 10 patients. Conclusions: This study indicates that (1) the prognosis of PDAC remains poor and (2) careful histopathological review of all patients with pancreatic cancer is mandatory if survival data are to be meaningful.
ACCESSION #
16348865

 

Related Articles

  • Stromal biology and therapy in pancreatic cancer. Albrecht Neesse // Gut;Jun2011, Vol. 60 Issue 6, p861 

    Pancreatic ductal adenocarcinoma (PDA) is an almost uniformly lethal disease. One explanation for the devastating prognosis is the failure of many chemotherapies, including the current standard of care therapy gemcitabine. Although our knowledge of the molecular events underlying multistep...

  • High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas. Yanagisawa, Nobuyuki; Ichinoe, Masaaki; Mikami, Tetuo; Nakada, Norihiro; Hana, Kiyomi; Koizumi, Wasaburo; Endou, Hitoshi; Okayasu, Isao // Journal of Clinical Pathology;Nov2012, Vol. 65 Issue 11, p1019 

    Background and aims Molecular target therapy against L-type amino acid transporter 1 (LAT1) is unique and expected to be developed soon. LAT1 expression was investigated in pancreatic cancer as a prognostic predictor. Methods Surgically resected pancreatic ductal adenocarcinomas (PDAC, n=66)...

  • Poor prognosis of common-type invasive ductal carcinomas that originate in the branching pancreatic duct. Ando, Masataka; Shimizu, Yasuhiro; Sano, Tsuyoshi; Senda, Yoshiki; Nimura, Yuji; Yamao, Kenji; Nagino, Masato; Yanagisawa, Akio // Surgery Today;Oct2015, Vol. 45 Issue 10, p1291 

    Purpose: To clarify the incidence, clinicopathological features and prognosis of pancreatic invasive ductal carcinomas (IDCs) with different tumor origin sites in the pancreatic duct. Methods: Based on the relationship between the invasive cancer area (ICA) and the main pancreatic duct (MPD),...

  • Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma. Saukkonen, Kapo; Hagström, Jaana; Mustonen, Harri; Juuti, Anne; Nordling, Stig; Fermér, Christian; Nilsson, Olle; Seppänen, Hanna; Haglund, Caj // PLoS ONE;Jun2015, Vol. 10 Issue 6, p1 

    Aim of the Study: Podocalyxin-like 1 is a transmembrane glyco-protein whose overexpression associates in many cancers with poor prognosis and unfavorable clinicopathological characteristics. Until now, its prognostic value has never been studied in pancreatic ductal adenocarcinoma (PDAC). The...

  • Ampullary adenocarcinoma -- differentiation matters. Schirmacher, Peter; Büchler, Markus W. // BMC Cancer;2008, Vol. 8, Special section p1 

    The periampullary region gives rise to two main subtypes of adenocarcinoma that show either pancreatobiliary or intestinal differentiation. New data demonstrates that the histological subtype -- more so than the anatomical location -- is an important independent prognostic factor. This fuels the...

  • IκB Kinase ε expression in pancreatic ductal adenocarcinoma. Cheng, Anna; Jianping Guo; Henderson-Jackson, Evita; Donghwa Kim; Malafa, Mokenge; Coppola, Domenico; Guo, Jianping; Kim, Donghwa // American Journal of Clinical Pathology;Jul2011, Vol. 136 Issue 1, p60 

    IκB kinase (IKKε) is a serine/threonine protein kinase that belongs to the IKK kinase family. Recent studies have shown that IKKε functions as a breast and ovarian cancer oncogene. We demonstrated frequent overexpression of IKKε in pancreatic ductal adenocarcinoma (PDA). We...

  • Risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Howes, N.; Neoptolemos, J.P. // Gut;Dec2002, Vol. 51 Issue 6, p765 

    Comments on research on the risk of pancreatic ductal adenocarcinoma in chronic pancreatitis. Research methodology; Biological evidence supporting the development of chronic pancreatitis to pancreatic ductal adenocarcinoma.

  • Impact of caveolin-I expression on prognosis of pancreatic ductal adenocarcinoma. Suzuoki, M.; Miyamoto, M.; Kato, K.; Hiraoka, K.; Oshikiri, T.; Nakakubo, Y.; Fukunaga, A.; Schichinohe, T.; Shinohara, T.; Itoh, T.; Katoh, H. // British Journal of Cancer;11/01/2002, Vol. 87 Issue 10, p1140 

    Investigates the relationship between caveolin-I expression and the clinicopathologic variables and clinical outcome in 79 patients with pancreatic adenocarcinoma undergoing surgical resection. Determination of caveolin-I expression by immunohistochemistry using a polyclonal anti-caveolin-I...

  • Does the mechanism of lymph node invasion affect survival in patients with pancreatic ductal adenocarcinoma? Konstantinidis, Ioannis T.; Deshpande, Vikram; Hui Zheng; Wargo, Jennifer A.; Fernandez-del Castillo, Carlos; Thayer, Sarah P.; Androutsopoulos, Vasiliki; Lauwers, Gregory Y.; Warshaw, Andrew L.; Ferrone, Cristina R.; Zheng, Hui // Journal of Gastrointestinal Surgery;Feb2010, Vol. 14 Issue 2, p261 

    Background: Lymph node metastases are prognostically significant in pancreatic ductal adenocarcinoma. Little is known about the significance of direct lymph node invasion.Aim: The aim of this study is to find out whether direct lymph node invasion has the same...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics